Read More 1 minute read Funding News News Latus Bio Launches with $54M for CNS Gene Therapies Key Highlights $54 million Series A financing led by 8VC and DCVC Bio. Focus on gene therapy candidates for CLN2… byChris-Anne RoqueMay 3, 2024
